More than 7% of patients participate in cancer clinical research trials, a new study shows—higher than the 5% historically reported. The findings, which were published in the Journal of Clinical Oncology, are the first to use national accreditation information from the Commission on Cancer (CoC) to more accurately estimate participation rates.